BCAS2
breast carcinoma amplified sequence 2
BCAS2; breast carcinoma amplified sequence 2; pre-mRNA-splicing factor SPF27; DAM1; Snt309; SPF27; DNA amplified in mammary carcinoma 1 protein; Spliceosome associated protein SPF 27; Breast carcinoma-amplified sequence 2; MGC7712; Pre mRNA splicing factor SPF27; SPF27_HUMAN; Spliceosome associated protein amplified in breast cancer; Spliceosome-associated protein SPF 27; OTTHUMP00000013668; spliceosome associated protein, amplified in breast cancer;
BRCA1
breast cancer 1, early onset
BRCA1; breast cancer 1, early onset; breast cancer type 1 susceptibility protein; BRCA1/BRCA2 containing complex; subunit 1; BRCC1; PPP1R53; protein phosphatase 1; regulatory subunit 53; RNF53; RING finger protein 53; BRCA1/BRCA2-containing complex, subunit 1; protein phosphatase 1, regulatory subunit 53; breast and ovarian cancer susceptibility protein 1; breast and ovarian cancer sususceptibility protein 1; IRIS; PSCP; BRCAI; PNCA4; BROVCA1;
SNCG
synuclein, gamma (breast cancer-specific protein 1)
SNCG; synuclein, gamma (breast cancer-specific protein 1); SR; BCSG1; gamma-synuclein; persyn; synoretin; breast cancer-specific gene 1 protein;
BCAR1
breast cancer anti-estrogen resistance 1
BCAR1; breast cancer anti-estrogen resistance 1; CAS; CAS1; CASS1; CRKAS; P130Cas; breast cancer anti-estrogen resistance protein 1; Crk-associated substrate p130Cas; Cas scaffolding protein family member 1;
BCAR3
breast cancer anti-estrogen resistance 3
BCAR3; breast cancer anti-estrogen resistance 3; breast cancer anti-estrogen resistance protein 3; NSP2; SH2D3B; BCAR 3; Novel SH2 containing protein 2; SH2 domain containing protein 3B; Breast cancer anti estrogen resistance 3; Breast cancer anti estrogen resistance protein 3; Breast cancer antiestrogen resistance 3; dJ1033H22.2; dJ1033H22.2 breast cancer anti estrogen resistance 3; dJ1033H22.2 breast cancer antiestrogen resistance 3; KIAA0554; NSP 2; SH2 containing protein Nsp2; OTTHUMP00000011959; OTTHUMP00000011960; OTTHUMP00000011961; OTTHUMP00000011962; novel SH2-containing protein 2; SH2 domain-containing protein 3B; dJ1033H22.2 (breast cancer anti-estrogen resistance 3);
BCAS1
breast carcinoma amplified sequence 1
BCAS1; breast carcinoma amplified sequence 1; breast carcinoma-amplified sequence 1; AIBC1; NABC1; novel amplified in breast cancer 1; amplified and overexpressed in breast cancer;
BRMS1
breast cancer metastasis suppressor 1
BRMS1; breast cancer metastasis suppressor 1; breast cancer metastasis-suppressor 1; DKFZP564A063; AV003220; AW554636; MGC95128; OTTHUMP00000235056; OTTHUMP00000235057; OTTHUMP00000235060; OTTHUMP00000235062;
EPSTI1
epithelial stromal interaction 1 (breast)
EPSTI1; epithelial stromal interaction 1 (breast); epithelial-stromal interaction protein 1; BRESI1; epithelial stromal interaction protein 1; MGC29634;
BRCA2
breast cancer 2, early onset
BRCA2; breast cancer 2, early onset; FACD, FANCD, FANCD1, Fanconi anemia, complementation group D1; breast cancer type 2 susceptibility protein; BRCA1/BRCA2 containing complex; subunit 2; BRCC2; FAD; FAD1; fanconi anemia group D1 protein; breast cancer 2;
BCAS3
breast carcinoma amplified sequence 3
BCAS3; breast carcinoma amplified sequence 3; breast carcinoma-amplified sequence 3; FLJ20128; 1500019F07Rik; 2610028P08Rik; AU021018; BC028339; BCAS3_HUMAN; GAOB1; K20D4; MAAB; Maab1 protein; MGC4973; rudhira; protein Maab1; BCAS4/BCAS3 fusion; metastasis associated antigen of breast cancer; breast carcinoma amplified sequence 4/3 fusion protein;
BCAS4
breast carcinoma amplified sequence 4
BCAS4; breast carcinoma amplified sequence 4; breast carcinoma-amplified sequence 4; CNOL; FLJ20495; BCAS4/BCAS3 fusion; breast carcinoma amplified sequence 4/3 fusion protein;
BRMS1L
breast cancer metastasis-suppressor 1-like
BRMS1L; breast cancer metastasis-suppressor 1-like; breast cancer metastasis suppressor 1 , BRMS1; breast cancer metastasis-suppressor 1-like protein; FLJ39177; MGC11296; breast cancer metastasis suppressor 1 like; BRM1L_HUMAN; BRMS1 homolog protein p40; BRMS1 like protein p40; BRMS1-homolog protein p40; BRMS1-like protein p40; BRMS1;
PBOV1
prostate and breast cancer overexpressed 1
PBOV1; prostate and breast cancer overexpressed 1; prostate and breast cancer overexpressed gene 1 protein; UC28; UROC28; PBOV 1; dJ171N11.2;
ST18
suppression of tumorigenicity 18 (breast carcinoma) (zinc finger protein)
ST18;suppression of tumorigenicity 18 (breast carcinoma) (zinc finger protein);18695;ENSG00000147488;ZNF387;8q11.23;KIAA0535;suppression of tumorigenicity 18 protein;suppression of tumorigenicity 18 protein;zinc finger protein 387;
An Approved Malarial Drug is Promising for Preventing and Stopping Breast Cancer
Explore New Aspects from Old ItemsChloroquine During a clinical trial, researchers of Mason Center unexpectedly found a malarial drugChloroquine can stop the precursor cells of breast cancer, which brings hope and new thoughts for patients and doctors. Thus they launch a PINC (Preventing Invasiv...